✨ Medicines Consent Notices




19 JUNE 2008 NEW ZEALAND GAZETTE, No. 100 2701

Product: Noxafil
Active Ingredient: Posaconazole 40mg/mL
Dosage Form: Oral Suspension
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Pantheon Inc, Whitby Operations, Whitby, Ontario, Canada
Note: This consent is valid for two years from 22 June 2008.

Dated this 12th day of June 2008.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Clomazol 2%
Active Ingredient: Clotrimazole 20mg/g
Dosage Form: Vaginal cream
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Salcette, Goa, India

Product: Kogenate FS
Active Ingredient: Octocog alfa 2,000IU
Dosage Form: Powder for injection
Diluent A
Diluent B
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Corporation, Berkeley, California, United States of America

Product: Lamisil Sole Repair
Active Ingredient: Terbinafine hydrochloride 10mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturers: Novartis Consumer Health SA, Prangins, Nyon, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany

Product: Pradaxa
Active Ingredient: Dabigatran etexilate 126.83mg
Dosage Form: Capsule
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Product: Pradaxa
Active Ingredient: Dabigatran etexilate 86.48mg
Dosage Form: Capsule
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Dated this 12th day of June 2008.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2008, No 100





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of Noxafil

πŸ₯ Health & Social Welfare
12 June 2008
Medicines, Consent, Noxafil, Posaconazole, Oral Suspension
  • ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
12 June 2008
Medicines, Consent, Clomazol, Kogenate FS, Lamisil Sole Repair, Pradaxa
  • ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
12 June 2008
Medicines, Consent, Changed Medicines
  • ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate